`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF DELAWARE
`
`GUARDANT HEALTH, INC.,
`
`Plaintiff,
`
`v.
`
`FOUNDATION MEDICINE, INC.,
`
`Defendant.
`
`)
`)
`)
`)
`)
`)
`)
`)
`)
`
`C.A. No. 20-cv-1580-LPS
`
`JURY TRIAL DEMANDED
`
`[PROPOSED] ORDER GRANTING PLAINTIFF GUARDANT HEALTH INC.’S
`MOTION FOR PRELIMINARY INJUNCTION
`
`
`
`Case 1:20-cv-01580-LPS Document 7-1 Filed 12/10/20 Page 2 of 2 PageID #: 673
`
`
`
`Plaintiff Guardant Health, Inc. (“Guardant”) moves for a preliminary injunction. In
`consideration of the entire record, Plaintiffs have demonstrated that it is likely to succeed on the
`merits of its patent infringement allegations against Defendants. Defendants have not presented
`a substantial question of the validity of those patents. In addition, Plaintiffs have demonstrated
`that they are substantially likely to suffer irreparable harm from Defendants’ ongoing
`infringement and that the balance of equities and the public interest favor protecting Plaintiffs
`and granting a preliminary injunction. Plaintiffs’ Motion for Preliminary Injunction is therefore
`GRANTED.
`
`Accordingly, IT IS HEREBY ORDERED :
`
`Defendants and their officers, agents, affiliates, employees, and attorneys, and all those
`
`persons acting or attempting to act in concert or participation with them, are enjoined from making,
`
`using, offering to sell, or selling within the United States, or importing into the United States, or
`
`marketing, promoting, or distributing the accused FoundationOne® Liquid CDx.
`
`Defendants are obligated to notify all users of the accused FoundationOne® Liquid CDx
`
`about this order.
`
`
`
`DATED: ______________, 2020
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`___________________________________
`
`UNITED STATES JUDGE
`
`
`
`1
`
`
`
`